Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: August 18, 2018

DrugPatentWatch Database Preview

Glenmark Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for GLENMARK PHARMS, and what generic and branded alternatives to GLENMARK PHARMS drugs are available?

GLENMARK PHARMS has sixty-seven approved drugs.

There are eight tentative approvals on GLENMARK PHARMS drugs.

Summary for Glenmark Pharms

US Patents:	0
Tradenames:	54
Ingredients:	51
NDAs:	67

Drugs and US Patents for Glenmark Pharms

+ Get email alerts for changes to this table

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Glenmark Pharms Ltd	NEBIVOLOL HYDROCHLORIDE	nebivolol hydrochloride	TABLET;ORAL	203821-001	May 25, 2017		DISCN	No	No		➤ Sign Up				➤ Sign Up
Glenmark Pharms Ltd	POTASSIUM CHLORIDE	potassium chloride	CAPSULE, EXTENDED RELEASE;ORAL	202868-001	Jan 19, 2016	AB	RX	No	No		➤ Sign Up				➤ Sign Up
Glenmark Pharms Ltd	LAMOTRIGINE	lamotrigine	TABLET, CHEWABLE;ORAL	079099-002	Feb 19, 2009	AB	RX	No	No		➤ Sign Up				➤ Sign Up
Glenmark Pharms Ltd	VORICONAZOLE	voriconazole	TABLET;ORAL	203503-001	Sep 2, 2015	AB	RX	No	No		➤ Sign Up				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi

UBS

McKinsey

Express Scripts

AstraZeneca

Johnson and Johnson

US Department of Justice

Julphar

Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.